Craig Hoesley

877 total citations
29 papers, 620 citations indexed

About

Craig Hoesley is a scholar working on Infectious Diseases, Epidemiology and Microbiology. According to data from OpenAlex, Craig Hoesley has authored 29 papers receiving a total of 620 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Infectious Diseases, 10 papers in Epidemiology and 9 papers in Microbiology. Recurrent topics in Craig Hoesley's work include Reproductive tract infections research (9 papers), HIV/AIDS Research and Interventions (9 papers) and HIV Research and Treatment (5 papers). Craig Hoesley is often cited by papers focused on Reproductive tract infections research (9 papers), HIV/AIDS Research and Interventions (9 papers) and HIV Research and Treatment (5 papers). Craig Hoesley collaborates with scholars based in United States, India and Canada. Craig Hoesley's co-authors include Stephen A. Moser, Mukesh Patel, Gretchen A. Cloud, Ken B. Waites, James R. Jackson, William S. Brooks, James L. Raper, Ross Cranston, Ian McGowan and Neil A. Accortt and has published in prestigious journals such as PLoS ONE, Clinical Infectious Diseases and The American Journal of Medicine.

In The Last Decade

Craig Hoesley

28 papers receiving 587 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Craig Hoesley United States	12	301	198	108	107	90	29	620
Craig Hoesley United States	14	576 1.9×	273 1.4×	202 1.9×	85 0.8×	18 0.2×	27	746
Uwe Koppe Germany	12	184 0.6×	352 1.8×	75 0.7×	114 1.1×	24 0.3×	36	865
Juliette Pavie France	16	629 2.1×	452 2.3×	285 2.6×	57 0.5×	25 0.3×	40	904
David B. Glasser United States	19	247 0.8×	353 1.8×	85 0.8×	206 1.9×	23 0.3×	36	1.4k
Robert Luo United States	17	460 1.5×	335 1.7×	54 0.5×	217 2.0×	15 0.2×	37	884
Andrea Kovacs United States	18	396 1.3×	385 1.9×	220 2.0×	73 0.7×	21 0.2×	28	776
Manuel Fernández Guerrero Spain	13	257 0.9×	192 1.0×	117 1.1×	56 0.5×	45 0.5×	46	588
Dawn Nolt United States	17	360 1.2×	419 2.1×	18 0.2×	73 0.7×	52 0.6×	34	795
Wing-Wai Wong Taiwan	12	339 1.1×	193 1.0×	195 1.8×	48 0.4×	19 0.2×	19	668
Miguel Ángel Sánchez-Alemán Mexico	14	86 0.3×	257 1.3×	19 0.2×	38 0.4×	19 0.2×	59	491

Countries citing papers authored by Craig Hoesley

Since Specialization

Citations

This map shows the geographic impact of Craig Hoesley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Craig Hoesley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Craig Hoesley more than expected).

Fields of papers citing papers by Craig Hoesley

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Craig Hoesley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Craig Hoesley. The network helps show where Craig Hoesley may publish in the future.

Co-authorship network of co-authors of Craig Hoesley

This figure shows the co-authorship network connecting the top 25 collaborators of Craig Hoesley. A scholar is included among the top collaborators of Craig Hoesley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Craig Hoesley. Craig Hoesley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Riddler, Sharon A., Clifton W. Kelly, Craig Hoesley, et al.. (2024). A Phase 1 Clinical Trial to Assess the Safety and Pharmacokinetics of a Tenofovir Alafenamide/Elvitegravir Insert Administered Rectally for HIV Prevention. The Journal of Infectious Diseases. 230(3). 696–705. 1 indexed citations

Benveniste, Etty, Robert P. Kimberly, Craig Hoesley, et al.. (2023). The Pittman Scholar Program for junior faculty recognition at the University of Alabama at Birmingham Heersink School of Medicine. Medical Education Online. 28(1). 2182188–2182188. 2 indexed citations

Vickers, Selwyn M., Anupam Agarwal, Nisha Patel, et al.. (2021). Returning to Growth: One Academic Medical Center’s Successful Five-Step Approach to Change Management. Academic Medicine. 96(10). 1401–1407. 3 indexed citations

deShazo, Richard D., Craig Hoesley, & Selwyn M. Vickers. (2020). Ending Racial Bias in American Medicine: A Call for Help from the AMA, NMA, AAMC, and the Rest of Us. The American Journal of Medicine. 134(5). 565–568. 22 indexed citations

Hoesley, Craig, et al.. (2020). University of Alabama School of Medicine. Academic Medicine. 95(9S). S15–S17. 1 indexed citations

Hoesley, Craig, et al.. (2019). 1733. Voriconazole Prophylaxis Following Allogeneic Hematopoietic Stem Cell Transplant: How Much Is Enough, Are Low Voriconazole Levels Associated With Opportunistic Infections, and What Are the Reasons for Discontinuation?. Open Forum Infectious Diseases. 6(Supplement_2). S635–S635. 1 indexed citations

Hess, Matthew C., et al.. (2018). Predictors of Patient Retention at a Student-Run Free Clinic. 4(1). 2 indexed citations

Lee, Rachael A, Bernard Camins, Russell Griffin, et al.. (2018). Improvement of gram-negative susceptibility to fluoroquinolones after implementation of a pre-authorization policy for fluoroquinolone use: A decade-long experience. Infection Control and Hospital Epidemiology. 39(12). 1419–1424. 13 indexed citations

Friedland, Barbara, Craig Hoesley, Marlena Plagianos, et al.. (2016). First-in-Human Trial of MIV-150 and Zinc Acetate Coformulated in a Carrageenan Gel: Safety, Pharmacokinetics, Acceptability, Adherence, and Pharmacodynamics. JAIDS Journal of Acquired Immune Deficiency Syndromes. 73(5). 489–496. 34 indexed citations

10.

Hladik, Florian, Adam Burgener, Lamar Ballweber, et al.. (2015). Mucosal effects of tenofovir 1% gel. eLife. 4. 51 indexed citations

11.

Cranston, Ross, Craig Hoesley, Alex Carballo‐Diéguez, et al.. (2013). A Randomized Male Tolerance Study of Dapivirine Gel Following Multiple Topical Penile Exposures (MTN 012/IPM 010). AIDS Research and Human Retroviruses. 30(2). 184–189. 7 indexed citations

12.

McGowan, Ian, Craig Hoesley, Ross Cranston, et al.. (2013). A Phase 1 Randomized, Double Blind, Placebo Controlled Rectal Safety and Acceptability Study of Tenofovir 1% Gel (MTN-007). PLoS ONE. 8(4). e60147–e60147. 82 indexed citations

13.

Evans, Hughes & Craig Hoesley. (2010). University of Alabama School of Medicine. Academic Medicine. 85(9 Suppl). S69–S73. 1 indexed citations

14.

Johnson, Victoria A., et al.. (2009). Novel Methodology for Antiretroviral Quantitation in the Female Genital Tract. HIV Clinical Trials. 10(3). 193–199. 6 indexed citations

15.

Patel, Mukesh, Ken B. Waites, Stephen A. Moser, Gretchen A. Cloud, & Craig Hoesley. (2006). Prevalence of Inducible Clindamycin Resistance among Community- and Hospital-Associated Staphylococcus aureus Isolates. Journal of Clinical Microbiology. 44(7). 2481–2484. 105 indexed citations

16.

Bachmann, Laura H., Renée A. Desmond, Kathleen Squires, et al.. (2004). Incidence and Risk Factors for Sexually Transmitted Infections among Women in an Alabama HIV Clinic. AIDS Research and Human Retroviruses. 20(6). 577–583. 5 indexed citations

17.

Kirby, Tyler O., Megan Allen, Ronald D. Alvarez, Craig Hoesley, & Warner K. Huh. (2004). High-Risk Human Papillomavirus and Cervical Intraepithelial Neoplasia at Time of Atypical Squamous Cells of Undetermined Significance Cytologic Results in a Population with Human Immunodeficiency Virus. Journal of Lower Genital Tract Disease. 8(4). 298–303. 17 indexed citations

18.

Bedimo, Roger, Ray Y. Chen, Neil A. Accortt, et al.. (2004). Trends in AIDS-Defining and Non--AIDS-Defining Malignancies among HIV-Infected Patients: 1989-2002. Clinical Infectious Diseases. 39(9). 1380–1384. 94 indexed citations

19.

Hoesley, Craig, Susan A. Allen, James L. Raper, et al.. (2002). Comparative Analysis of Commercial Assays for the Detection and Quantification of Human Immunodeficiency Virus Type 1 (HIV‐1) RNA in Plasma from Patients Infected with HIV‐1 Subtype C. Clinical Infectious Diseases. 35(3). 323–325. 11 indexed citations

20.

Hoesley, Craig, et al.. (2000). Prolonged Suppression of Human Immunodeficiency Virus Type 1 RNA during Dual Nucleoside Reverse‐Transcriptase–Inhibitor Therapy in Clinical Practice. Clinical Infectious Diseases. 31(4). 1095–1097. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact